The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research

Treatment-resistant schizophrenia (TRS), the persistence of positive symptoms despite ≥2 trials of adequate dose and duration of antipsychotic medication with documented adherence, is a serious clinical problem with heterogeneous presentations. TRS can vary in its onset (at the first episode of psyc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:NPJ Schizophr
Autors principals: Potkin, Steven G., Kane, John M., Correll, Christoph U., Lindenmayer, Jean-Pierre, Agid, Ofer, Marder, Stephen R., Olfson, Mark, Howes, Oliver D.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6946650/
https://ncbi.nlm.nih.gov/pubmed/31911624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41537-019-0090-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars